AI assistant
Sending…
Clene Inc. — Director's Dealing 2022
Feb 4, 2022
34487_dirs_2022-02-04_33c381a8-2261-4a78-a3fb-aadbfd403078.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Clene Inc. (CLNN)
CIK: 0001822791
Period of Report: 2022-02-03
Reporting Person: Gay Jonathon (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-03 | Stock Options (Right to buy) | $2.71 | A | 5473.00 | Acquired | 2032-02-03 | Common Stock (5473.00) | Direct |
Footnotes
F1: This option was granted on February 3, 2022 as an option for 5,473 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $2.71 per share. The options vest immediately upon grant.
More from Clene Inc.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 4
Annual Report
2026
Mar 17
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 20